Figure 3. Mean dose of ketorolac (mean+/-SD). At 0 and 24 h, the mean dosage of ketorolac taken by group A was higher than the dosage taken by groups B, C, and P (*P < 0.05). There was no difference in dosage among the other groups. At 4 h, the dosage for group A was higher than for group C (*P < 0.05). There was no difference in dosage among the other groups. At 8 h, group A took a higher dosage than groups B, C, and P (*P < 0.05), consumption in group B was higher than in groups C and P (sup o P < 0.05). There was no difference in consumption between groups C and P. At 12 h, consumption for group B was higher than for groups C and P (*P < 0.05). There was no difference in consumption among the other groups. Analysis of variance for each time point was carried out using Sheffe's test.

Figure 3. Mean dose of ketorolac (mean+/-SD). At 0 and 24 h, the mean dosage of ketorolac taken by group A was higher than the dosage taken by groups B, C, and P (*P < 0.05). There was no difference in dosage among the other groups. At 4 h, the dosage for group A was higher than for group C (*P < 0.05). There was no difference in dosage among the other groups. At 8 h, group A took a higher dosage than groups B, C, and P (*P < 0.05), consumption in group B was higher than in groups C and P (sup o P < 0.05). There was no difference in consumption between groups C and P. At 12 h, consumption for group B was higher than for groups C and P (*P < 0.05). There was no difference in consumption among the other groups. Analysis of variance for each time point was carried out using Sheffe's test.

Close Modal

or Create an Account

Close Modal
Close Modal